Replies to post #240845 on Biotech Values

[DewDiligence]

CSL.AX—(-16%)—takes $5M writeoff for Vifor business, which has turned out to be a bust:

https://www.nasdaq.com/articles/csl-sees-5-bln-non-cash-impairments-cuts-fy26-outlook-stock-plunges